» Articles » PMID: 21068248

Quantitative Studies of Epstein-Barr Virus-encoded MicroRNAs Provide Novel Insights into Their Regulation

Overview
Journal J Virol
Date 2010 Nov 12
PMID 21068248
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Epstein-Barr virus (EBV) has been shown to encode at least 40 microRNAs (miRNAs), an important class of molecules that negatively regulate the expression of many genes through posttranscriptional mechanisms. Here, we have used real-time PCR assays to quantify the levels of EBV-encoded BHRF1 and BART miRNAs in latently infected cells and in cells induced into the lytic cycle. During latency, BHRF1 miRNAs were seen only in cells with detectable Cp- and/or Wp-initiated EBNA transcripts, while the BART miRNAs were expressed in all forms of latent infection. Surprisingly, levels of different BART miRNAs were found to vary up to 50-fold within a cell line. However, this variation could not be explained by differential miRNA turnover, as all EBV miRNAs appeared to be remarkably stable. Following entry into the virus lytic cycle, miR-BHRF1-2 and -1-3 were rapidly induced, coincident with the onset of lytic BHRF1 transcripts, while miR-BHRF1-1 expression was delayed until 48 h and correlated with the appearance of Cp/Wp-initiated EBNA transcripts. In contrast, levels of BART miRNAs were relatively unchanged during virus replication, despite dramatic increases in BART transcription. Finally, we show that BHRF1 and BART miRNAs were delayed relative to the induction of BHRF1 and BART transcripts in freshly infected primary B cell cultures. In summary, our data show that changes in BHRF1 and BART transcription are not necessarily reflected in altered miRNA levels, suggesting that miRNA maturation is a key step in regulating steady-state levels of EBV miRNAs.

Citing Articles

Epigenetic Mechanisms in Latent Epstein-Barr Virus Infection and Associated Cancers.

Torne A, Robertson E Cancers (Basel). 2024; 16(5).

PMID: 38473352 PMC: 10931536. DOI: 10.3390/cancers16050991.


Markers of Epstein-Barr Virus Infection in Patients with Multiple Sclerosis.

Debuysschere C, Nekoua M, Hober D Microorganisms. 2023; 11(5).

PMID: 37317236 PMC: 10220565. DOI: 10.3390/microorganisms11051262.


EBV-microRNAs as Potential Biomarkers in EBV-related Fever: A Narrative Review.

Wang W, Yang Y, Zhang Y, Le Y, Wu Y, Liu Y Curr Mol Med. 2022; 24(1):2-13.

PMID: 36411555 PMC: 10825793. DOI: 10.2174/1566524023666221118122005.


The Influence of Host miRNA Binding to RNA Within RNA Viruses on Virus Multiplication.

Lei L, Cheng A, Wang M, Jia R Front Cell Infect Microbiol. 2022; 12:802149.

PMID: 35531344 PMC: 9069554. DOI: 10.3389/fcimb.2022.802149.


Epstein-Barr Virus miR-BHRF1-3 Targets the BZLF1 3'UTR and Regulates the Lytic Cycle.

Fachko D, Chen Y, Skalsky R J Virol. 2021; 96(4):e0149521.

PMID: 34878852 PMC: 8865410. DOI: 10.1128/JVI.01495-21.


References
1.
Shannon-Lowe C, Baldwin G, Feederle R, Bell A, Rickinson A, Delecluse H . Epstein-Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowth. J Gen Virol. 2005; 86(Pt 11):3009-3019. DOI: 10.1099/vir.0.81153-0. View

2.
Cai X, Schafer A, Lu S, Bilello J, Desrosiers R, Edwards R . Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2006; 2(3):e23. PMC: 1409806. DOI: 10.1371/journal.ppat.0020023. View

3.
Kim D, Chae H, Oh S, Kang J, Park C, Park W . Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol. 2006; 81(2):1033-6. PMC: 1797424. DOI: 10.1128/JVI.02271-06. View

4.
Fabian M, Sonenberg N, Filipowicz W . Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010; 79:351-79. DOI: 10.1146/annurev-biochem-060308-103103. View

5.
Lewis B, Burge C, Bartel D . Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120(1):15-20. DOI: 10.1016/j.cell.2004.12.035. View